van der Wall SJ, Teutsch C, Dubner SJ, Diener HC, Halperin JL, Ma CS, Rothman KJ, Paquette M, Zint K, Franca LR, Lu S, Lip GYH, Huisman MV, GLORIA-AF Investigators. Anticoagulation prescription and outcomes in relation to renal function in patients with atrial fibrillation: results from GLORIA-AF. TH Open. 2021 Feb 6;5(1):e35-42. doi: 10.1055/s-0040-1722706
van den Dries CJ, van Doorn S, Souverein P, Pajouheshnia R, Moons KGM, Hoes AW, Gerrsing G-J, van den Ham HA. The number of concomitant drugs and the safety of direct oral anticoagulants in routine care patients with atrial fibrillation. TH Open. 2020 Dec 23;4(4):e417-26. doi: 10.1055/s-0040-1721499
Van Hout B, Hawe E, Cohen AT. Impact of patient characteristics on treatment outcomes in symptomatic venous thromboembolism: results of HOKUSAI-VTE randomized trial analysis. TH Open. 2020 Sep 23;4(3):e245-54. doi: 10.1055/s-0040-1716496
Skajaa N, Horvath-Puho E, Adelborg K, Prandoni P, Rothman KJ, Sorensen HT. Venous thromboembolism in Denmark: seasonality in occurrence and mortality. TH Open. 2019 Jun 18;3(2):e171-9. doi: 10.1055/s-0039-1692399.
Hong J, Novick D, Montgomery W, Aguado J, Dueñas H, Peng X, Haro JM. Should unexplained painful physical symptoms be considered within the spectrum of depressive symptoms? Clin Pract Epidemiol Ment Health. 2015 Mar 31;11:130-9. doi: 10.2174/1745017901511010130
Estrada CA, Unterborn JN, Price J, Thompson D, Gibson L. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Eff Clin Pract. 2000 Sep 1;3(5):221-8.